
A Biomarker, an App, and Real-World Data: How Biogen is Trying to Improve Treatment for Patients With Multiple Sclerosis
As part of their work to support the treatment of patients with multiple sclerosis, Biogen has been investigating a potential new biomarker for the disease called serum neurofilament light (sNfL),…